The response to the current wave of the disease, which has caused 139 deaths in central Africa to date, has been hampered by security concerns

Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the Democratic Republic of the Congo and Uganda.

There are currently no approved Bundibugyo virus-specific therapeutics or vaccines and the extent of the spread is uncertain, the WHO says.

The WHO is investigating potential vaccines and treatments for a potentially lengthy Ebola outbreak in the Democratic Republic of Congo, which has been declared an international…